Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015)

Spyre Therapeutics (SYRE) reported Preferred Dividend Payments of $228000.0 for Q1 2015.

Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015) Analysis & Trends

Spyre Therapeutics has reported Preferred Dividend Payments for 1 years, with the latest figure at $228000.0 in Q1 2015.

For the quarter ending Q1 2015, Preferred Dividend Payments changed N/A year-over-year to $228000.0; the trailing twelve-month figure through Dec 2015 stood at $228000.0 (changed N/A YoY), and the FY2015 full-year result was $228000.0, changed N/A from the prior year.
Preferred Dividend Payments for Q1 2015 stood at $228000.0.
The five-year high for Preferred Dividend Payments was $228000.0 in Q1 2015, with the low at $228000.0 in Q1 2015.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Spyre Therapeutics	6.95 Bn	6.95 Bn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2015	228,000.00